Go to deals
Healthcare | TMT

MJH Associates has acquired UBM Life Sciences’ healthcare media assets from Informa

January 2019 — MJH Associates‚ Inc. (MJH) has acquired major market media assets from the UBM Life Sciences Group of Informa PLC (INF.L). The transaction consideration was in excess of US$100 million.

MJH is the largest privately held, independent full-service medical media company in the US dedicated to delivering trusted healthcare news across multiple channels. Over 600 MJH associates are dedicated to providing healthcare professionals with the information and resources they need to optimize patient outcomes. MJH combines the reach and influence of its powerful portfolio of digital and print product lines, live events, educational programs and market research with the customization capabilities of a boutique firm. Clients include world-leading pharmaceutical, medical device, diagnostic and biotech companies.

The acquisition of UBM Life Sciences Group assets includes iconic multimedia platforms in the healthcare, animal care, pharma sciences and dental fields as well as three preeminent veterinarian conferences.

Informa is a leading international exhibitions, events, information services and scholarly research group with annual revenues approaching US$4 billion. It helps commercial, professional and academic communities work smarter and make better decisions faster, through specialist content and intelligence, and provide opportunities to connect and learn.

Our role in the transaction

One of Oaklins’ TMT specialist teams in New York acted as the exclusive M&A advisor to MJH Associates in this transaction.

Parties
“The strategic purchase of UBM Life Sciences’ media assets leaves no question that MJH Life Sciences is dedicated to remaining at the forefront of delivering trusted healthcare information now and into the future. It furthers our overall commitment to providing diverse stakeholders — from providers to patients to caregivers — with access to trusted and timely resources to help inform care and optimize outcomes.”

Michael J. Hennessy Jr.

President, MJH Associates, Inc.

Talk to the deal team

Roland DeSilva

Senior Advisor
New York, United States
Oaklins DeSilva+Phillips

Jack Noble

Partner
New York, United States
Oaklins DeSilva+Phillips

Related deals

Heka Dental has joined forces with Impilo to anchor focused buy-and-build strategy
Private Equity | Healthcare

Heka Dental has joined forces with Impilo to anchor focused buy-and-build strategy

Heka Dental, a leading Danish designer and manufacturer of premium dental treatment units, has been acquired by the Swedish private equity firm Impilo. The acquisition establishes Heka Dental as a strategic platform for consolidation in the European dental equipment market. Impilo will execute a focused buy-and-build strategy to accelerate growth and expand its footprint across Europe.

Learn more
itemedical has been acquired by Halma
Healthcare | TMT

itemedical has been acquired by Halma

itemedical, a Netherlands-based provider of digital platforms that integrate real-time patient data and alarms from a wide range of medical devices to support clinical decision-making and workflow efficiency in hospitals, has been acquired by Halma plc, a global group of life-saving technology companies. The acquisition represents a milestone in itemedical’s development and provides a platform for its next phase of growth. By joining Halma’s healthcare sector as a business unit of Halma subsidiary Static Systems Group (SSG), itemedical will strengthen its position as a provider of digital hospital workflow solutions, benefiting from access to a global network of technology businesses, resources to accelerate innovation and opportunities to expand its international footprint.

Learn more
Evoke Creative has been acquired by Steliau Technology
TMT

Evoke Creative has been acquired by Steliau Technology

Private equity firm BGF has sold Evoke Creative Ltd., an international provider of interactive digital solutions, to Steliau Technology, a company backed by Astorg Partners. Evoke will continue to operate as an independent brand while benefiting from the wider group’s support to accelerate international expansion, increase product innovation and strengthen its position in key vertical markets.

Learn more